On the basis of these findings, we propose that the increased level of β-catenin in HCC, which is observed in approximately 50–70% of HCC29, provides a growth advantage to tumor cells by promoting their proliferation via upregulation of Irs1. The gene discussed is IRS1; the disease is hepatocellular carcinoma.